Progressive MS: Neuroinflammation, NF-kB, and the Unexpected Role of Ginger

Progressive multiple sclerosis—whether primary (PPMS) or secondary (SPMS)—is the most disabling and least treatable form of MS. Unlike the relapsing-remitting form, conventional disease-modifying treatments have limited efficacy in progressive forms, which are dominated by chronic neurodegeneration rather than acute inflammatory relapses.

Mechanisms of Progressive MS: NF-kB and Microglia

In progressive MS, the disease driver is not peripheral autoimmunity (T cells in the blood) but intrinsic CNS neuroinflammation:

• Chronically activated microglia: microglia (resident macrophages of the brain) are activated by myelin debris and produce TNF-α, IL-1β, NO, and free radicals via NF-kB
• Reactive astrocytes: transformed into pro-inflammatory A1 phenotype under the influence of NF-kB → neurotoxicity
• cortisol-naturel">ginger mitochondrial oxidative stress: neurons in chronic lesions accumulate mitochondrial damage → energy deficit → axonal apoptosis
• Remyelination failure: oligodendrocyte precursors cannot mature due to the NF-kB-dependent inflammatory environment

Gingerol and Neuroinflammation: Promising Preliminary Data

Several in vitro and in vivo studies show that active ginger compounds partially cross the blood-brain barrier (BBB) and exert neuroprotective effects:

• NF-kB microglia inhibition: 6-gingerol reduces microglial activation and TNF-α production by 45% in neuroinflammation models (Neurochemistry International, 2019)
• Oligodendrocyte protection: gingerol protects oligodendrocytes from oxidative stress in EAE models (experimental autoimmune encephalomyelitis, the animal model of MS) (Multiple Sclerosis Journal, 2020)
• Nrf2 activation: induces glutathione and superoxide dismutase production in astrocytes and neurons → reduction of mitochondrial oxidative stress
• Effects on BBB: gingerol reduces BBB permeability by inhibiting NF-kB-induced MMPs (matrix metalloproteinases)

Important Limitations to Clarify

It is crucial to be honest: progressive MS is an extremely complex disease and these data, while promising, are primarily preclinical. Gingerol is not an MS treatment. Patients on natalizumab, ocrelizumab, siponimod, or other DMTs should not modify their treatment without neurological advice. INTI can be considered as a general anti-inflammatory ginger supplement, not as a therapeutic alternative.

INTI in the Context of Progressive MS

For progressive MS patients seeking documented complementary approaches:

• Mediterranean diet rich in polyphenols (oleocanthal, resveratrol, gingerol) → reduction of neuroinflammation
• INTI 15ml/day: provides gingerol without excess sugar (sugar activates NF-kB and worsens neuroinflammation)
• Vitamin D (2000-4000 IU/day depending on serum levels): essential in MS
• Adapted aerobic physical activity: demonstrably reduces activated microglia

Conclusion

Progressive MS is dominated by chronic neuroinflammation via NF-kB and microglia—a target on which gingerol exerts documented, albeit preliminary, effects. INTI, sugar-free and artisanally prepared, is the cleanest vector of gingerol available. A reasoned supplement—not a treatment—in the integrative management of progressive MS.

Informational article only. MS imperatively requires specialized neurological follow-up and appropriate background treatment.